Ptc Therapeutics (PTCT) Inventory (2017 - 2026)

Ptc Therapeutics' Inventory history runs 10 years deep, the most recent figure standing at $75.6 million for Q1 2026.

• On a quarterly basis, Inventory rose 248.64% year-over-year to $75.6 million in Q1 2026; TTM through Mar 2026 was $75.6 million, a 248.64% increase from a year earlier, with the FY2025 full-year figure at $79.6 million, up 243.39% from the prior year.
• Inventory retreated to $75.6 million in Q1 2026 per PTCT's latest filing, from $79.6 million in the prior quarter.
• Across five years, Inventory topped out at $79.6 million in Q4 2025 and bottomed at $14.8 million in Q3 2022.
• The 5-year median for Inventory is $30.6 million (2023), against an average of $33.9 million.
• Across the five-year window, Inventory declined 27.89% in 2025 and soared 248.64% in 2026, its largest moves.
• Year by year, Inventory stood at $21.8 million in 2022, then surged by 40.21% to $30.6 million in 2023, then declined by 24.15% to $23.2 million in 2024, then jumped by 243.39% to $79.6 million in 2025, then dropped by 5.12% to $75.6 million in 2026.
• Per Business Quant, the three latest PTCT Inventory figures stand at $75.6 million (Q1 2026), $79.6 million (Q4 2025), and $52.7 million (Q3 2025).